Chilton Investment Company’s Repligen RGEN Stock Holding History

Chilton Investment Company’s Portfolio RGEN Stock Details RGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-2,000	Closed	-$383K	–	164
2020 Q4	$383K	Buy	+2,000	New	+$364K	0.01%	116

Other funds holding RGEN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

1WCM

12 West Capital Management New York $592M AUM 40.75% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Chilton Investment Company's RGEN Position: Q1 2021 in Review

Chilton Investment Company sold out of Repligen (RGEN) in Q1 2021, closing a stake of 2,000 shares — an estimated $383K sold.

Chilton Investment Company first reported a position in RGEN in Q4 2020 and held it in 1 quarter. The position peaked at $383K in Q4 2020. 458 funds tracked by Wall St. Rank hold RGEN as of Q1 2021.

Chilton Investment Company reported no remaining Repligen position as of Q1 2021 after selling out during the quarter.
Chilton Investment Company sold 2,000 Repligen shares in Q1 2021, an estimated $383K.
Chilton Investment Company first reported a position in Repligen in Q4 2020 and held it in 1 quarter.
Chilton Investment Company's Repligen position peaked at $383K in Q4 2020.
458 funds tracked by Wall St. Rank held Repligen as of Q1 2021.

Based on Chilton Investment Company's 13F filing for Q1 2021, filed 11 May 2021.